Suraksha Disgnostic 
Dealstreet

Cyril Amarchand Mangaldas, JSA act on Suraksha Diagnostic IPO

The IPO plans to raise Rs. 846 crores.

Bar & Bench

Suraksha Diagnostic Limited has made an initial public offering aggregating to Rs. 846 Crore, comprising of an offer for sale by OrbiMed Asia II Mauritius Limited, Dr. Somnath Chatterjee, Ritu Mittal, Satish Kumar Verma, Munna Lal Kejriwal and Santosh Kumar Kejriwal.

Cyril Amarchand Mangaldas advised Suraksha Diagnostics on this IPO.

The transaction team was led by Priyadarshini Rao (Partner).

JSA advised the Bankers ICICI Securities Limited, Nuvama Wealth Management Limited and SBI Capital Markets Limited on this IPO.

The transaction team consisted of Arka Mookerjee (Lead Partner), Pracheta Bhattacharya (Partner), Sourav Modi (Senior Associate), Dhvanit Kothari (Associate), Jeebitesh Bhattacharya (Associate), Ankesh Kumar (Associate) and Anoop Mukundan (Junior Associate).

Arka Mookerjee, Pracheta Bhattacharya

Suraksha Diagnostic Limited offers one-stop integrated solutions for pathology and radiology testing and medical consultation services through their operational network consisting of a central reference laboratory, satellite laboratories, diagnostic centres, and sample collection centres.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Also Read

When lawyering becomes criminal: The Supreme Court's chance to protect the defenders of rule of law

'Intention' and the dynamics of caste abuse in the Atrocities Act

Don't burden yourself with loan for foreign LL.M: CJI BR Gavai to law graduates

Swiss Army Knife maker gets urgent relief from Bombay HC against unauthorised listings on Amazon

Kanwar Yatra: Plea in Supreme Court against UP govt mandate for QR codes at eateries to reveal owner name

SCROLL FOR NEXT